john greden (56 resultados)

gebundene Ausgabe. Condición: Gut. 290 Seiten; Der Erhaltungszustand des hier angebotenen Werks ist trotz seiner Bibliotheksnutzung sehr sauber. Es befindet sich neben dem Rückenschild lediglich ein Bibliotheksstempel im Buch; ordnungsgemäß entwidmet. Sprache: Englisch Gewicht in Gramm: 580.

Condición: very_good.

Condición: Very Good. Pages intact with possible writing/highlighting. Binding strong with minor wear. Dust jackets/supplements may not be included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.

Condición: Good. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.

Condición: Good. Item in good condition. Textbooks may not include supplemental items i.e. CDs, access codes etc.

Cartoné BB. Condición: Bueno. Estado de la sobrecubierta: Bueno. 1. Lleva firma de anterior propietario.\nWhen Emil Kraepelin and Eugen Bleuler consolidated the concepts of dementia praccox and schizophrenia almost a century ago, they considered negative symptoms to represent the core psychopathology. The importance of negative symptoms in schizophrenia was, however, downplayed until the past decade, which has been characterized by a profusion of studies in this area. The renewal of interest in these most fundamental symptoms of schizophrenia, while exciting and long overdue, has led to a certain degree of confusion with competing concepts and definitions. This book critically discusses the current status of negative schizophrenic symptoms with regard to their conceptualization, pathophysiology, etiology, and treatment.\n More than 30 experts of international renown contribute to this volume on negative schizophrenic symptoms.\n Negative Schizophrenic Symptoms: \nPathophysiology and Clinical\nImplications discusses the validity of various competing concepts; reviews current biochemical, structural, and developmental theories to explain negative symptoms; outlines pharmacological and other treatment approaches; and delineates promising areas for future research. In the first section of the book, the concepts and clinical features of the negative-symptom syndrome are discussed. In the next section, the contributors review various biochemical hypotheses formulated to explain negative symptoms. The third section discusses structural, developmental, genetic, and environmental theories of negative schizophrenic symptoms. The fourth section addresses pharmacological and other treatment approaches to negative symptoms. In the final chapter, the authors inquire as to how the various concepts and pathophysiological theories of the negative-symptom construct might be integrated. Colección: Progress in Psychiatry Nº de colección: 28. Libros.

Encuadernación de tapa blanda. Condición: Como Nuevo. X2002J06708. 338g. 192pp. Estado: como nuevo. Psiquiatría.

Condición: New. pp. xviii + 189.

Condición: New. pp. xviii + 189 Illus.

Condición: New.

Cartoné BB. Condición: Como nuevo. Estado de la sobrecubierta: Como nuevo. 1. Lleva firma del anterior propietario.\nThere is a great range in the severity of depressive disorders, and Severe Depressive Disorders is the first book\nto provide an in-depth look at the most severe end of the spectrum. The book is oriented toward the care of\npatients who require specific attention, careful treatment, and detailed prognostic assessment. Severe Depressive Disorders is designed to help improve the understanding and knowledge of treatment approaches to depressive disorders.\n\nWritten by a group of distinguished contributors, Severe Depressive Disorders presents original concepts\nconcerning the causes ofand treatment for patients withsevere depressive disorders,\n Colección: Progress in Psychiatry Nº de colección: 44. Libros.

Condición: New. pp. xviii + 189.

Condición: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Condición: As New. Unread book in perfect condition.

Paperback. Condición: New. Based on powerful epidemiological data such as numbers afflicted, mortality rates from suicide, personal and familial consequences, and skyrocketing fiscal costs, major depressive disorder (MDD) has the sad and ignominious distinction of being a leader among disabling disorders world-wide. This volume focuses on recurrences - perhaps most important among the many factors (from underdiagnosis and undertreatment to genetic vulnerability) that contribute to MDD's high morbidity.Its authors emphasize five critical topics: MDD's effect on women during three key periods of hormone transition - adolescence, childbearing years, and middle life; treatment strategies for chronic and recurrent depression, specifically addressing the continuing question of whether pharmacotherapy and psychotherapy combinations are superior to either alone; prevention of recurrences in patients with bipolar disorde r, updating the demonstrated benefits of several new anticonvulsant mood stabilizers and integrative treatment approaches; potential applications of new somatic treatment strategies, with data that suggest the efficacy of vagal nerve stimulation (VNS) and repetitive transcranial magnetic stimulation (TMS); and a "call to arms" with updated recommendations on how to ensure demonstrable, lasting progress in preventing recurrences of depression.

PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.

Condición: As New. Unread book in perfect condition.

Paperback Jun 30, 2001. Condición: Used: Good. 1194.

PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.

Condición: New.

Paperback. Condición: New. As many as 35-40% of patients afflicted with Major Depressive Disorder (MDD) are treatment resistant, a situation that places a massive emotional and financial burden on society and challenges the mental health profession to develop new treatment paradigms and practices. Even the most astute clinicians can be frustrated when treatment options fail to be effective or work for only a brief time, leaving them to wonder what course to pursue next. Treatment Resistant Depression: A Roadmap for Effective Care gives clinicians and their patients what they need most desperately: a sequence of steps that reflect state-of-the-art diagnostic procedures and integrates all evidence-based treatment modalities - in short, a roadmap to wellness and recovery.Based primarily on the experiences of the authors, all of whom are leading researchers and/or clinicians in Treatment Resistant Depression and affiliated with the University of Michigan Comprehensive Depression Center, the book also draws upon the clinical research advances and treatment innovations of programs around the world. Although the book's step-by-step organization is clear and easy to follow, its coverage, scope, and level of sophistication are anything but simplified. This book ; Is comprehensive, addressing treatment options, including psychopharmacotherapy, psychotherapy, neuromodulation (ECT, transcranial magnetic stimulation, deep brain stimulation, vagus nerve stimulation), exercise, nutrition, self-management approaches to enhance adherence, behavioral sleep programs, and others; Addresses treatment resistant depression across the lifespan, reflecting the diverse demographics of depression, which knows no age, gender, or socioeconomic status; Emphasizes the authors' commitment to early intervention and provides techniques for identifying young people who are at risk for developing depression or already expressing symptoms of the disease; Recognizes the chronicity of depression, rather than focusing on only the acute stage, and in this way allows for more effective treatment over the patient's lifetime; Introduces self-management as playing a critical role in the patient's prognosis, engagement, adherence to clinical steps that help maintain recovery, and self-esteem; Promotes the development of new, personalized, and predictive biomarkers to target treatment more effectively. Designed to be useful across disciplines and treatment modalities, the book includes a multitude of tables, graphs, and learning aids that will benefit students, instructors, and clinicians. At the same time, the book promises to be a valuable resource for patients and their families, since Treatment Resistant Depression is both difficult to live with and little understood. No other book offers so much practical guidance, sound research and hope.

Condición: New.

Paperback. Condición: new. Paperback. Based on powerful epidemiological data such as numbers afflicted, mortality rates from suicide, personal and familial consequences, and skyrocketing fiscal costs, major depressive disorder (MDD) has the sad and ignominious distinction of being a leader among disabling disorders world-wide. This volume focuses on recurrences - perhaps most important among the many factors (from underdiagnosis and undertreatment to genetic vulnerability) that contribute to MDD's high morbidity.Its authors emphasize five critical topics: MDD's effect on women during three key periods of hormone transition - adolescence, childbearing years, and middle life; treatment strategies for chronic and recurrent depression, specifically addressing the continuing question of whether pharmacotherapy and psychotherapy combinations are superior to either alone; prevention of recurrences in patients with bipolar disorde r, updating the demonstrated benefits of several new anticonvulsant mood stabilizers and integrative treatment approaches; potential applications of new somatic treatment strategies, with data that suggest the efficacy of vagal nerve stimulation (VNS) and repetitive transcranial magnetic stimulation (TMS); and a "call to arms" with updated recommendations on how to ensure demonstrable, lasting progress in preventing recurrences of depression. This hard-hitting volume focuses on recurrencesperhaps most important among the many factors (from underdiagnosis and undertreatment to genetic vulnerability) that contribute to MDD's high morbidity. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

Condición: As New. Unread book in perfect condition.

Condición: New.

Paperback. Condición: new. Paperback. As many as 35-40% of patients afflicted with Major Depressive Disorder (MDD) are treatment resistant, a situation that places a massive emotional and financial burden on society and challenges the mental health profession to develop new treatment paradigms and practices. Even the most astute clinicians can be frustrated when treatment options fail to be effective or work for only a brief time, leaving them to wonder what course to pursue next. Treatment Resistant Depression: A Roadmap for Effective Care gives clinicians and their patients what they need most desperately: a sequence of steps that reflect state-of-the-art diagnostic procedures and integrates all evidence-based treatment modalities - in short, a roadmap to wellness and recovery.Based primarily on the experiences of the authors, all of whom are leading researchers and/or clinicians in Treatment Resistant Depression and affiliated with the University of Michigan Comprehensive Depression Center, the book also draws upon the clinical research advances and treatment innovations of programs around the world. Although the book's step-by-step organization is clear and easy to follow, its coverage, scope, and level of sophistication are anything but simplified. This book ; Is comprehensive, addressing treatment options, including psychopharmacotherapy, psychotherapy, neuromodulation (ECT, transcranial magnetic stimulation, deep brain stimulation, vagus nerve stimulation), exercise, nutrition, self-management approaches to enhance adherence, behavioral sleep programs, and others; Addresses treatment resistant depression across the lifespan, reflecting the diverse demographics of depression, which knows no age, gender, or socioeconomic status; Emphasizes the authors' commitment to early intervention and provides techniques for identifying young people who are at risk for developing depression or already expressing symptoms of the disease; Recognizes the chronicity of depression, rather than focusing on only the acute stage, and in this way allows for more effective treatment over the patient's lifetime; Introduces self-management as playing a critical role in the patient's prognosis, engagement, adherence to clinical steps that help maintain recovery, and self-esteem; Promotes the development of new, personalized, and predictive biomarkers to target treatment more effectively. Designed to be useful across disciplines and treatment modalities, the book includes a multitude of tables, graphs, and learning aids that will benefit students, instructors, and clinicians. At the same time, the book promises to be a valuable resource for patients and their families, since Treatment Resistant Depression is both difficult to live with and little understood. No other book offers so much practical guidance, sound research and hope. This unique book presents the treatment "roadmap" implemented by the University of Michigan Comprehensive Depression Center's Treatment Resistant Depression Program, step-by-step guidance that has long eluded clinicians, patients, and their families. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

Condición: New. In.

Paperback / softback. Condición: New. New copy - Usually dispatched within 4 working days.

Condición: As New. Unread book in perfect condition.

Condición: New. In.